Immunome Cash Flow Statement (2019-2026) | IMNM

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-7.72M-7.76M-11.75M-10.73M-11.93M-8.08M-4.57M-16.07M-15.83M-94.72M-132.40M-86.23M-116.13M-83.27M-44.90M-70.30M-101.90M-72.87M-244.25M-248.28M
Share-based Compensation (Quarter)
1.16M1.22M1.31M1.33M1.34M1.35M1.22M1.03M1.08M1.10M2.16M3.23M4.89M5.47M5.70M5.35M6.75M7.89M7.95M89.80M
Gains from Investment Securities (Quarter)
Cash from Operations (Quarter)
-4.14M-6.80M-6.38M-8.06M-7.57M-6.68M24.17M-5.67M-8.61M-17.46M-11.17M-23.40M-34.17M-42.06M-53.05M-49.40M-40.51M-47.95M-58.64M-61.69M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.84M0.54M0.35M1.47M0.54M0.82M1.21M0.82M0.45M
Amortization of Deferred Charges (Quarter)
0.03M0.01M0.01M0.17M0.05M0.06M0.06M0.11M0.11M0.12M0.16M0.14M0.12M0.08M0.14M0.15M0.15M0.20M
Depreciation & Amortization (CF) (Quarter)
0.29M0.12M0.11M0.11M0.10M0.07M0.09M0.10M0.11M0.19M0.16M0.55M0.41M0.48M0.61M0.64M0.59M0.66M0.60M0.96M
Change in Working Capital
Change in Account Payables (Quarter)
1.60M-0.31M0.79M1.39M-2.12M-0.74M0.69M0.59M-1.21M-0.68M2.40M-0.03M-2.11M9.27M-3.81M-4.95M1.87M-2.28M1.42M1.19M
Change in Accured Expenses (Quarter)
2.50M2.47M-0.91M-2.43M0.87M0.55M-1.40M1.37M-1.42M2.07M0.67M6.90M5.94M0.04M-8.52M0.62M6.74M5.70M-9.75M7.90M
Other Working Capital Changes (Quarter)
1.96M2.46M-3.97M-0.47M-0.79M0.17M-0.21M-1.00M-0.34M5.70M-2.47M1.60M-1.39M1.36M1.71M3.60M-1.86M0.04M5.10M6.90M
Investing Activities
Capital Expenditures (Quarter)
-0.01M0.08M0.01M0.17M0.07M0.22M0.22M-0.13M0.06M0.59M3.91M1.54M1.13M3.67M-2.38M4.40M4.00M3.00M2.18M
Change in Acquisitions & Divestments (Quarter)
30.00M85.00M15.00M60.00M125.00M
Cash from Investing Activities (Quarter)
-0.03M-0.01M-0.01M-0.17M-0.07M-0.11M-0.34M-0.04M-30.00M-37.23M-81.69M24.10M9.76M5.09M-64.17M123.88M-4.00M-12.02M-304.35M
Financing Activities
Other financing activities (Quarter)
0.05M0.03M0.03M64.00M3.43M0.30M-1.71M0.21M-0.21M0.23M1.06M
Cash from Financing Activities (Quarter)
0.58M-0.20M0.03M0.03M60.88M55.50M219.44M0.69M0.30M20.09M162.23M-0.06M45.39M432.80M-0.14M1.06M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.03M125.00M20.00M44.90M0.43M
Additional items
Change in Cash (Quarter)
-3.59M-7.01M-6.35M-8.23M-7.57M-6.75M24.10M-6.01M52.23M8.04M171.04M-104.39M-9.76M-12.22M114.26M-113.63M128.76M380.84M-70.79M-364.99M
Free Cash Flow (Quarter)
-4.14M-6.88M-6.38M-8.23M-7.57M-6.75M23.95M-5.89M-8.48M-17.52M-11.76M-27.31M-35.71M-43.19M-56.72M-47.02M-44.91M-51.95M-61.64M-63.87M
Net Cash Flow (Quarter)
-3.59M-7.01M-6.35M-8.23M-7.57M-6.75M24.10M-6.01M52.23M8.04M171.04M-104.39M-9.76M-12.22M114.26M-113.63M128.76M380.84M-70.79M-364.99M